GE HealthCare Technologies (GEHC) Cash from Operations (2022 - 2026)
GE HealthCare Technologies (GEHC) posted Cash from Operations of 290000000.0 for Q1 2026, down 72.38% on a QoQ basis from 1050000000.0 in Q4 2025, and up 16.0% year-over-year from 250000000.0 in Q1 2025.
GE HealthCare Technologies (GEHC) Cash from Operations (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' Cash from Operations history runs 5 years deep, the most recent figure standing at 290000000.0 for Q1 2026.
- Quarterly Cash from Operations rose 16.0% year-over-year to 290000000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2027000000.0 (up 13.49% YoY) and the FY2025 annual result came in at 1987000000.0, up 1.64% from the prior year.
- Cash from Operations was 290000000.0 for Q1 2026 at GE HealthCare Technologies, down from 1050000000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1063000000.0 in Q4 2022 and bottomed at 119000000.0 in Q2 2024.
- A 5-year average of 498058823.53 and a median of 468000000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations plunged 252.63% — and 2025, when it surged 178.99%.
- GE HealthCare Technologies' Cash from Operations stood at 1063000000.0 in 2022, then fell by 1.22% to 1050000000.0 in 2023, then declined by 13.05% to 913000000.0 in 2024, then advanced by 15.01% to 1050000000.0 in 2025, then sank by 72.38% to 290000000.0 in 2026.
- Business Quant data shows GEHC's Cash from Operations at 290000000.0 in Q1 2026, 1050000000.0 in Q4 2025, and 593000000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 335.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 290.00 Mn |
| Mar 31, 2026 | 290.00 Mn |
| Dec 31, 2025 | 1.05 Bn |
| Dec 31, 2025 | 1.05 Bn |
| Sep 30, 2025 | 593.00 Mn |
| Sep 30, 2025 | 593.00 Mn |
| Jun 30, 2025 | 94.00 Mn |
| Jun 30, 2025 | 94.00 Mn |
| Mar 31, 2025 | 250.00 Mn |
| Mar 31, 2025 | 250.00 Mn |
| Dec 31, 2024 | 913.00 Mn |
| Dec 31, 2024 | 913.00 Mn |
| Sep 30, 2024 | 742.00 Mn |
| Sep 30, 2024 | 742.00 Mn |
| Jun 30, 2024 | -119.00 Mn |
| Jun 30, 2024 | -119.00 Mn |
| Mar 31, 2024 | 419.00 Mn |
| Mar 31, 2024 | 419.00 Mn |
| Dec 31, 2023 | 1.05 Bn |
| Dec 31, 2023 | 1.05 Bn |